KEGG   DRUG: Mecasermin rinfabate
Entry
D04870                      Drug                                   
Name
Mecasermin rinfabate (USAN/INN);
Iplex (TN)
Formula
C1231H1967N371O384S20
Exact mass
28731.0209
Mol weight
28749.345
Sequence
(IGF-I) GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR
SCDLRRLEMY CAPLKPAKSA
(IGFBP-3) GASSAGLGPV VRCEPCDARA LAQCAPPPAV CAELVREPGC GCCLTCALSE
GQPCGIYTER CGSGLRCQPS PDEARPLQAL LDGRGLCVNA SAVSRLRAYL LPAPPAPGNA
SESEEDRSAG SVESPSVSST HRVSDPKFHP LHSKIIIIKK GHAKDSQRYK VDYESQSTDT
QNFSSESKRE TEYGPCRREM EDTLNHLKFL NVLSPRGVHI PNCDKKGFYK KKQCRPSKGR
KRGFCWCVDK YGQPLPGYTT KGKEDVHCYS MQSK
  Type
Peptide
Remark
ATC code: H01AC05
Chemical structure group: DG01359
Product (DG01359): D03297<JP/US>
Efficacy
Antidiabetic, Insulin-like growth factor receptor agonist
Target
IGF1R (CD221) [HSA:3480] [KO:K05087]
GHR [HSA:2690] [KO:K05080]
  Pathway
hsa04151  PI3K-Akt signaling pathway
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
  H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
   H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
    H01AC Somatropin and somatropin agonists
     H01AC05 Mecasermin rinfabate
      D04870  Mecasermin rinfabate (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   INSR family
    IGF1R (CD221)
     D04870  Mecasermin rinfabate (USAN/INN)
 Cytokines and receptors
  Cytokine receptors
   CSF and other factor receptors
    GHR
     D04870  Mecasermin rinfabate (USAN/INN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D04870
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D04870
Other DBs
CAS: 478166-15-3
PubChem: 47206641
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system